Dr. Allen Bott, MD
NPI: 1770577652
Total Payments
$674,531
2024 Payments
$29,622
Companies
23
Transactions
1,093
Medicare Patients
910
Medicare Billing
$196,876
Payment Breakdown by Category
Other$537,754 (79.7%)
Travel$73,883 (11.0%)
Consulting$44,623 (6.6%)
Food & Beverage$18,161 (2.7%)
Education$111.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $537,754 | 290 | 79.7% |
| Travel and Lodging | $73,883 | 407 | 11.0% |
| Consulting Fee | $44,623 | 16 | 6.6% |
| Food and Beverage | $18,161 | 373 | 2.7% |
| Education | $111.59 | 7 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $175,402 | 225 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $99,950 | 138 | $0 (2018) |
| Allergan, Inc. | $99,354 | 206 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $75,372 | 110 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $67,866 | 126 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $39,868 | 78 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $31,229 | 41 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $22,738 | 47 | $0 (2022) |
| Eisai Inc. | $22,661 | 27 | $0 (2021) |
| Axsome Therapeutics, Inc. | $15,119 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,622 | 44 | Neurocrine Biosciences, Inc. ($16,205) |
| 2023 | $37,334 | 54 | Neurocrine Biosciences, Inc. ($27,473) |
| 2022 | $33,720 | 32 | Neurocrine Biosciences, Inc. ($30,731) |
| 2021 | $51,344 | 65 | Neurocrine Biosciences, Inc. ($30,617) |
| 2020 | $58,158 | 85 | Allergan, Inc. ($24,099) |
| 2019 | $76,729 | 157 | Neurocrine Biosciences, Inc. ($29,003) |
| 2018 | $188,617 | 323 | Takeda Pharmaceuticals U.S.A., Inc. ($60,496) |
| 2017 | $199,008 | 333 | Merck Sharp & Dohme Corporation ($86,629) |
All Payment Transactions
1,093 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,710.00 | General |
| Category: Neuropsychiatry | ||||||
| 10/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $129.75 | General |
| Category: Neuropsychiatry | ||||||
| 10/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: Neuropsychiatry | ||||||
| 09/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $97.90 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Central Nervous System | ||||||
| 09/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: Neuropsychiatry | ||||||
| 08/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: Neuropsychiatry | ||||||
| 08/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,710.00 | General |
| Category: Neuropsychiatry | ||||||
| 08/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $347.71 | General |
| Category: Neuropsychiatry | ||||||
| 07/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Central Nervous System | ||||||
| 06/05/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $274.00 | General |
| 05/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $80.00 | General |
| Category: Neuropsychiatry | ||||||
| 05/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $42.41 | General |
| Category: Neuropsychiatry | ||||||
| 05/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $26.13 | General |
| Category: Neuropsychiatry | ||||||
| 05/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Neuropsychiatry | ||||||
| 05/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Consulting Fee | Cash or cash equivalent | $7,155.00 | General |
| Category: Neuropsychiatry | ||||||
| 04/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $269.35 | General |
| Category: Neuropsychiatry | ||||||
| 04/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $257.96 | General |
| Category: Neuropsychiatry | ||||||
| 04/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $45.36 | General |
| Category: Neuropsychiatry | ||||||
| 04/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $37.15 | General |
| Category: Neuropsychiatry | ||||||
| 04/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $35.10 | General |
| Category: Neuropsychiatry | ||||||
| 04/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 241 | 484 | $86,057 | $54,184 |
| 2022 | 4 | 249 | 469 | $85,672 | $55,101 |
| 2021 | 4 | 209 | 419 | $71,342 | $47,983 |
| 2020 | 5 | 211 | 399 | $61,864 | $39,607 |
Total Patients
910
Total Services
1,771
Medicare Billing
$196,876
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 373 | $61,067 | $38,367 | 62.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 52 | $12,581 | $7,906 | 62.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $8,203 | $5,236 | 63.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 18 | 29 | $4,206 | $2,675 | 63.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 335 | $55,776 | $35,280 | 63.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 55 | 73 | $16,875 | $10,932 | 64.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 33 | 33 | $9,231 | $6,194 | 67.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 20 | 28 | $3,791 | $2,695 | 71.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 129 | 310 | $49,483 | $32,611 | 65.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 38 | 52 | $11,406 | $7,799 | 68.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 20 | 20 | $5,304 | $3,921 | 73.9% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 22 | 37 | $5,149 | $3,652 | 70.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 134 | 293 | $41,689 | $26,391 | 63.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 31 | 51 | $9,662 | $5,991 | 62.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 16 | 16 | $4,239 | $2,930 | 69.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 17 | 26 | $3,378 | $2,409 | 71.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $2,896 | $1,886 | 65.1% |
About Dr. Allen Bott, MD
Dr. Allen Bott, MD is a Neurology with Special Qualifications in Child Neurology healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770577652.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allen Bott, MD has received a total of $674,531 in payments from pharmaceutical and medical device companies, with $29,622 received in 2024. These payments were reported across 1,093 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($537,754).
As a Medicare-enrolled provider, Bott has provided services to 910 Medicare beneficiaries, totaling 1,771 services with total Medicare billing of $196,876. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology with Special Qualifications in Child Neurology
- Location Oakland, CA
- Active Since 09/07/2005
- Last Updated 11/20/2019
- Taxonomy Code 2084N0402X
- Entity Type Individual
- NPI Number 1770577652
Products in Payments
- INGREZZA (Drug) $173,238
- Trintellix (Drug) $106,519
- BELSOMRA (Drug) $99,950
- VRAYLAR (Drug) $68,449
- REXULTI (Drug) $67,867
- AJOVY (Drug) $26,771
- NAMZARIC (Drug) $24,296
- Dayvigo (Drug) $22,661
- LATUDA (Drug) $22,163
- UBRELVY (Drug) $18,622
- Auvelity (Drug) $15,092
- NUPLAZID (Drug) $11,985
- AJOVY (Biological) $9,271
- NUEDEXTA (Drug) $328.00
- TRINTELLIX (Drug) $128.06
- LONHALA MAGNAIR (Drug) $101.39
- AUSTEDO (Drug) $73.23
- Ongentys (Drug) $63.75
- ADUHELM (Biological) $60.91
- Aimovig (Biological) $49.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology with Special Qualifications in Child Neurology Doctors in Oakland
Dr. Ali Mostajelean, M.d, M.D
Neurology with Special Qualifications in Child Neurology — Payments: $7,232
Neurology with Special Qualifications in Child Neurology $7,232
Rachel Kuperman, M.d, M.D
Neurology with Special Qualifications in Child Neurology — Payments: $4,874
Neurology with Special Qualifications in Child Neurology $4,874
Dr. Jennifer Martelle Tu, Md, Ph.d, MD, PH.D
Neurology with Special Qualifications in Child Neurology — Payments: $3,761
Neurology with Special Qualifications in Child Neurology $3,761
Daniel Birnbaum, M.d, M.D
Neurology with Special Qualifications in Child Neurology — Payments: $373.46
Neurology with Special Qualifications in Child Neurology $373.46
Keely Fitzgerald, Do, DO
Neurology with Special Qualifications in Child Neurology — Payments: $336.58
Neurology with Special Qualifications in Child Neurology $336.58
Sabrina Smith, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $21.08
Neurology with Special Qualifications in Child Neurology $21.08